“Fractional Flow Reserve Market To Reach $2.19 Billion By 2029”, says Visiongain report

19 December 2019
Energy

Visiongain’s new report the Fractional Flow Reserve Market Report 2019-2029: Forecasts by Technology [Invasive Monitoring (Pressure Guidewires, FFR Measurement Systems), Non-Invasive Monitoring], by Application (Single-Vessel Diseases, Multi-Vessel Diseases), plus analysis of leading companies operating in the global fractional flow reserve market.

The global fractional flow reserve market size was valued at $510 million in 2019 and is expected to generate market revenue of more than $2 billion by the end of 2029. Market growth is primarily attributed by increasing geriatric population in the U.S., European countries, and Japan. Additionally, the growing prevalence of cardiovascular diseases such as high blood pressure and coronary artery diseases will increase fractional flow reserve market expansion over the course of the period. According to the report of the American Heart Association on heart diseases, in 2018, cardiovascular disease accounted for more than 800,000 deaths in the United States.

Rising geriatric population in developed as well as developing economies is expected to increase penetration of chronic diseases and will encourage fractional flow reserve market over the coming years. According to the World Health Organization, the global population aged 60 years or more was more than 900 million in 2018, more than twice as large as in 1980 when there were 382 million older persons worldwide. The number of older persons is expected to double again by 2050 when it is projected to reach nearly 2.1 billion.

North America dominated the global fractional flow reserve market in 2019 by accounting more than 40% of the overall market share. Regional growth was primarily driven by the presence of well-established healthcare infrastructure and supportive government policies for healthcare penetration. Additionally, manufacturers operating in this region are adopting mergers & acquisitions and research & development strategies to increase market concentration and increase the customer base. For instance, in January 2017, Abbott Laboratories, a U.S. based healthcare company engaged in medical devices, nutrition products, generic pharmaceuticals, and diagnostics acquired St. Jude Medical, Inc., an American medical device company.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Oil & Gas Pipeline Leak Detection Market Report 2021-2031

The COVID-19 crisis has dramatically affected oil and gas production and demand, leaving no midstream markets untouched as drilling screeched to a halt, pipeline projects were sidelined and global storage neared capacity in a stark reversal of trends at the start of 2020.

25 November 2020

Read

Visiongain Publishes Chemical Enhanced Oil Recovery (EOR) Market Report 2020-2030

Increasing oil consumption, high recovery rates through successful implementation of CEOR, coupled with high cost of new exploration is expected to drive the implementation of CEOR over the coming years.

22 October 2020

Read

Visiongain Publishes Carbon Capture, Transportation & Storage Market Report 2021-2031

Visiongain expects that various public support mechanisms will remain the principal driver throughout the forecast period. Estimates for the cost of CCS range between research papers as well as between capture technologies and plant characteristics.

02 October 2020

Read

Visiongain Publishes Coal Tar Market Report 2020-2030

Supply gap due to production halt brought about by COVID-19 pandemic is expected restrict sales growth. However, the rising demand for coal tar products from the healthcare sector is expected to stabilize market growth during the forecast period.

25 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever